Capital Analysts LLC’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,960	Closed	-$642K	–	1432
2024 Q4	$642K	Hold	1,960	–	–	0.03%	303
2024 Q3	$588K	Buy	1,960 +235	+14%	+$72K	0.02%	300
2024 Q2	$568K	Hold	1,725	–	–	0.03%	311
2024 Q1	$683K	Hold	1,725	–	–	0.03%	286
2023 Q4	$607K	Sell	1,725 -50	-3%	-$17.7K	0.03%	293
2023 Q3	$666K	Sell	1,775 -170	-9%	-$65.7K	0.04%	261
2023 Q2	$744K	Hold	1,945	–	–	0.04%	251
2023 Q1	$674K	Buy	1,945 +5	+0.3%	+$1.46K	0.04%	264
2022 Q4	$457K	Sell	1,940 -45	-2%	-$10.7K	0.03%	309
2022 Q3	$488K	Sell	1,985 -601	-23%	-$183K	0.03%	271
2022 Q2	$782K	Buy	2,586 +25	+1%	+$8.13K	0.05%	231
2022 Q1	$1.05M	Hold	2,561	–	–	0.07%	213
2021 Q4	$1.2M	Sell	2,561 -29	-1%	-$12.5K	0.07%	202
2021 Q3	$1.1M	Hold	2,590	–	–	0.07%	203
2021 Q2	$929K	Buy	2,590 +35	+1%	+$11.6K	0.06%	211
2021 Q1	$720K	Buy	2,555 +635	+33%	+$182K	0.05%	226
2020 Q4	$544K	Buy	1,920 +340	+22%	+$95.4K	0.05%	186
2020 Q3	$434K	Buy	1,580 +165	+12%	+$43.7K	0.04%	203
2020 Q2	$321K	Sell	1,415 -80	-5%	-$15.7K	0.03%	202
2020 Q1	$228K	Buy	+1,495	New	+$230K	0.03%	199